About Index Trending news
Lists
Pricing
Merus

Merus

Merus

Merus is focused on the use of two proprietary technologies to build a pipeline of innovative human therapeutic antibodies: the OligoclonicsTM and MeMoTM Technologies.

Elsewhere

Alexa global traffic share

Latest funding
IPO
$55,000,000
Employees

Team size

10+
Locations
HQ
TechCrunch

Ask A VC: Merus Capital's Sean Dempsey On The Role Of Corp Dev And More